Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
5.60
-0.31 (-5.25%)
At close: Nov 20, 2024, 4:00 PM
5.72
+0.12 (2.14%)
After-hours: Nov 20, 2024, 6:44 PM EST
Terns Pharmaceuticals Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for TERN stock have an average target of 16.42, with a low estimate of 7.50 and a high estimate of 26. The average target predicts an increase of 193.21% from the current stock price of 5.60.
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for TERN stock from 6 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 3 | 2 | 2 | 2 |
| Buy | 2 | 2 | 2 | 2 | 3 | 3 |
| Hold | 2 | 2 | 2 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 8 | 8 | 7 | 5 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Hold Maintains $5.5 → $7.5 | Hold | Maintains | $5.5 → $7.5 | +33.93% | Nov 13, 2024 |
| Oppenheimer | Oppenheimer | Buy Initiates $17 | Buy | Initiates | $17 | +203.57% | Oct 31, 2024 |
| BMO Capital | BMO Capital | Buy Reiterates $19 → $26 | Buy | Reiterates | $19 → $26 | +364.29% | Sep 16, 2024 |
| JMP Securities | JMP Securities | Buy Maintains $15 → $20 | Buy | Maintains | $15 → $20 | +257.14% | Sep 10, 2024 |
| JMP Securities | JMP Securities | Buy Reiterates $15 | Buy | Reiterates | $15 | +167.86% | Sep 3, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.30
from -1.27
EPS Next Year
-1.42
from -1.30
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | n/a | n/a | n/a | ||
| Avg | n/a | n/a | n/a | ||
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | -1.22 | -1.28 | -0.08 | ||
| Avg | -1.30 | -1.42 | -1.17 | ||
| Low | -1.38 | -1.60 | -1.59 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | - | - | - | ||
| Avg | - | - | - | ||
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.